6-Ethoxydihydrosanguinarine
CAS No. 28342-31-6
6-Ethoxydihydrosanguinarine( —— )
Catalog No. M22806 CAS No. 28342-31-6
6-Ethoxydihydrosanguinarine shows human blood acetylcholinesterase (HuAChE) and human plasma butyrylcholinesterase (HuBuChE) inhibitory activity, with IC50 values of 0.83 +/- 0.04 microM and 4.20 +/- 0.19 microM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 149 | In Stock |
|
| 10MG | 239 | In Stock |
|
| 25MG | 384 | In Stock |
|
| 50MG | 527 | In Stock |
|
| 100MG | 752 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name6-Ethoxydihydrosanguinarine
-
NoteResearch use only, not for human use.
-
Brief Description6-Ethoxydihydrosanguinarine shows human blood acetylcholinesterase (HuAChE) and human plasma butyrylcholinesterase (HuBuChE) inhibitory activity, with IC50 values of 0.83 +/- 0.04 microM and 4.20 +/- 0.19 microM, respectively.
-
Description6-Ethoxydihydrosanguinarine shows human blood acetylcholinesterase (HuAChE) and human plasma butyrylcholinesterase (HuBuChE) inhibitory activity, with IC50 values of 0.83 +/- 0.04 microM and 4.20 +/- 0.19 microM, respectively.
-
In VitroEthoxysanguinarine inhibits cells vialibity with IC50 of 9.37 μM (SW480 cells); 7.19μM (HCT116 cells); 6.55 μM (HT69 cells); 3.57 μM (SW620 cells).Ethoxysanguinarine (3 μM or 5 μM, 24 h) down-regulates phospho-Akt, decreases CIP2A/PP2A/Akt pathway expression in the SW620 and HT29 cells.Ethoxysanguinarine (3 μM or 5 μM, 24 h) increases the PP2A activity and inhibits phosphorylation of CIP2A downstream molecule protein kinase B.Ethoxysanguinarine (1-3 μM or 4.5-5 μM, 24 h) decreases CIP2A transcription (protein level) and induces CIP2A proteolysis in the SW620 and HT29 cells. Cell Viability Assay Cell Line:Colorectal cancer (CRC) cell lines: SW620, SW480, HT29 and HCT116 Concentration:0.5-12 μM Incubation Time:24 hours Result:Inhibited the viability of CRC cells with IC50 of 3.57-9.37 μM.Apoptosis Analysis Cell Line:Colorectal cancer (CRC) cell lines: SW620, HT29 Concentration:0-3 μM or 0-5 μM, respectively Incubation Time:24 hours Result:Induced caspase-dependent apoptosis in colorectal cancer (CRC) cells.
-
In VivoEthoxysanguinarine (0.5 mg/kg; s.c.; 5 times per week; 4 weeks) represses colorectal cancer (CRC) xenograft tumors growth in mice. Animal Model:Nude immunodeficient mice (5-week-old, weighing about 16 g)Dosage:0.5 mg/kg Administration:Subcutaneous injection; 5 times per week for 4 weeks Result:Exhibited antitumor effects without reduce the body weight of the mice.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorHuAChE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number28342-31-6
-
Formula Weight377.39
-
Molecular FormulaC22H19NO5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 60 mg/mL (158.99 mM)
-
SMILESCN1C2=C3C(C=C4OCOC4=C3)=CC=C2C5=C(C6=C(OCO6)C=C5)C1OCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Chelidonium majus (Papaveraceae).Nat Prod Commun. 2010 Nov;5(11):1751-4.
molnova catalog
related products
-
Tropicamide
Tropicamide is an anticholinergic and a Muscarinic Receptor subtype M4-preferring antagonist .
-
PNU-282987 S enantio...
PNU-282987 S enantiomer free base is an ?agonist of α7 nicotinic acetylcholine receptor (α7 nAChR).
-
(+)-Pilocarpine hydr...
Pilocarpine hydrochloride is a nonselective muscarinic acetylcholine receptor agonist used to produce an experimental model of epilepsy.
Cart
sales@molnova.com